The Beckley Med clinical area has created a protocol based on the American Psychiatric Association (APA) Consensus Statement on the use of Ketamine and the clinical studies that provide the highest level of scientific evidence to date.

The proposed intervention combines pharmacological treatment with elements of 3 therapeutic modalities that have shown promising empirical results in people diagnosed with treatment-resistant depression.

When used in a supervised setting at low doses, ketamine therapy is quite safe. You will have fully trained healthcare professionals by your side throughout your treatment. As with any treatment, there are potential risks and side effects. Before you begin your Beckley Med treatment, you’ll meet with our medical team to make sure it’s a good option for you.

Ketamine treatment has been shown to be effective in people diagnosed with major depression and therefore antidepressant resistance. Unlike antidepressants, ketamine has no side effects. Another big difference is the speed of action: half of the patients substantially improve their symptoms in just two days, a key factor in diluting suicidal thoughts.